Grant Papanek Julie 的 Form 4/A 修正申報
修正Day One Biopharmaceuticals, Inc.（DAWN），2022/7/12 申報
- 申報編號
- 0001209191-22-041994
- 申報時間
- 2022/7/12
- 交易日
- 2022/7/1-7/5
- 申報延遲
- 11 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
- 原始申報日
- 2022/7/6
這份申報列了 2 筆非衍生性交易。公開市場賣出合計 $3.60 萬。交易後 11 天申報。
這份修正申報取代了 0001209191-22-041408（2022/7/6 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Grant Papanek JulieCIK 0001673237 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/7/1 | Common Stock | S賣出處分 | −1,000 | $20.00 | −$20,000 | 464,000 | 間接 | |
| 2022/7/5 | Common Stock | S賣出處分 | −800 | $20.00 | −$16,000 | 463,200 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 28, 2021.
- F2
Represents shares held by The Grant Family Delaware Trust Agreement of which the Reporting Person is trustee. The Reporting Person disclaims beneficial ownership of the shares except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Act"), or for any other purpose.
- F3
This amendment to Form 4 is filed to include holdings by The Adam and Julie Grant Revocable Trust dtd October 13, 2017 (the "Revocable Trust"), of which the Reporting Person and her spouse are co-trustees, that were inadvertently omitted from the Form 4 filed on July 6, 2022. These shares were received by the Revocable Trust in one or more prior distributions-in-kind by Canaan XI L.P. for no consideration pursuant to the exemptions afforded by Rules 16a-9 and 16a-13 of the Act. The Reporting Person disclaims beneficial ownership of the shares except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Act, or for any other purpose.
- F4
Represents shares held by Canaan XI L.P. The Reporting Person is a non-managing member of Canaan Partners XI LLC, the general partner of Canaan XI L.P. The Reporting Person does not have voting or dispositive power over any of the shares held directly by Canaan XI L.P. and disclaims beneficial ownership of the shares except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Act, or for any other purpose.